Bayer’s nutritional business declined for the past year due to a weaker market environment in China and South East Asia, the company said in its FY23 financial results.
Bayer, which owns vitamin brands Redoxon, Berocca, and CDR, has reported “high double digit” online growth in a number of Southeast Asian markets, spurring it to reinforce its digital first strategy in the region.
